Drug Topics

SEPTEMBER 22, 2023

Limited veterinary pharmacy training is available, other than a handful of pharmacy schools that provide elective courses on the topic.

526

526

PharmaVoice

SEPTEMBER 22, 2023

Despite lower-than-expected demand for a competing treatment, DBV’s chief medical officer says the company’s topical skin patch could be a game-changing option for patients.

FDA 306

FDA 306

Drug Topics

SEPTEMBER 22, 2023

Treatment with buprenorphine has more than doubled since 2009, but dosing guidelines are based on studies with people using heroin that were done before the fentanyl crisis.

503

503

Pharmacy Times

SEPTEMBER 22, 2023

Empagliflozin (Jardiance) demonstrated a 28% relative risk reduction, with an absolute risk reduction of 3.6% per patient-year at risk in the treatment of chronic kidney disease.

FDA 156

FDA 156

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

SEPTEMBER 22, 2023

This is the fourth approval for the drug, stemming from the EMPOWER clinical trial program.

FDA 502

FDA 502

Pharmacy Times

SEPTEMBER 22, 2023

The House Committee members examined pricing tactics by PBMs and how they are harming patients across the country.

149

149

Pharmacy Times

SEPTEMBER 22, 2023

Heather Moore, CPP, PharmD, highlights key contributions from pharmacists in breast cancer treatment and identifies current unmet needs in the treatment landscape.

149

149

Drug Topics

SEPTEMBER 22, 2023

With a laundry list of upcoming changes, it’s more important than ever before that independent pharmacies work together.

Independent Pharmacies 247

Independent Pharmacies 247

STAT

SEPTEMBER 22, 2023

Two Democratic senators are warning the Food and Drug Administration not to proceed with a controversial trial meant to measure opioids’ effectiveness as a chronic pain treatment. In a letter shared with STAT, Sens. Ed Markey (D-Mass.) and Joe Manchin (D-W.Va.) warned FDA Commissioner Robert Califf against using the method in the agency’s ongoing work to evaluate whether opioids, despite their widespread use, are effective at treating chronic pain.

FDA 145

FDA 145

Pharmacy Times

SEPTEMBER 22, 2023

The people who come to the community pharmacy represent the surrounding population at large, making the pharmacy an ideal place to identify and recruit underrepresented patients.

Community Pharmacies 145

Community Pharmacies 145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 22, 2023

Late last summer, Elizabeth Jacques brought her youngest daughter, Elena, for a medical checkup. At the time, Jacques and her family were experiencing housing instability after a two-year legal battle with their former landlord, who refused to clean up their unsanitary, unlivable conditions. For Jacques, it was obvious she had to leave a housing situation that was putting her family’s health at risk.

Immunization 145

Immunization 145

Pharmacy Times

SEPTEMBER 22, 2023

Chemotherapy, medication for attention deficit/hyperactivity disorder, glucagon-like peptide-1 agonists for weight loss and diabetes, and local anesthetics were among the drugs most affected by shortages.

Chemotherapy 144

Chemotherapy 144

STAT

SEPTEMBER 22, 2023

Pfizer’s new shot to protect infants against respiratory syncytial virus by vaccinating their mothers late in pregnancy won a limited recommendation Friday from an expert panel that advises the Centers for Disease Control and Prevention, clearing the way for a second product to protect babies against RSV to soon hit the market. The recommendation was accepted by CDC Director Mandy Cohen shortly after the conclusion of the panel’s meeting.

Vaccines 145

Vaccines 145

Pharmacy Times

SEPTEMBER 22, 2023

Standard amount of pre-workout should be taken at least 13.2 hours before bedtime to avoid sleep disruptions; however, there was no cut-off time for a cup of black tea.

139

139

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

SEPTEMBER 22, 2023

At the height of the pandemic, when everything was shut down, a patient with whom I had a long-term relationship developed suicidal ideation. A male adolescent who lived in poverty, he was not able to call me on his smartphone because he had run out of minutes. And he was ashamed to use his parents’ telephone because of privacy issues. Fortunately, he was able to find help.

140

140

Pharmacy Times

SEPTEMBER 22, 2023

Tune in to this episode of Pharmacy Focus to gain a deeper understanding of the AAPT Fall Seminar, the evolving landscape of pharmacy practice, and the crucial roles played by pharmacy technicians.

139

139

Fierce Healthcare

SEPTEMBER 22, 2023

Cigna is facing another lawsuit over its PxDx tool, which has garnered controversy amid concerns that the insurer is using it to reject claims en masse. | Cigna is facing another lawsuit over its PxDx tool, which has garnered controversy amid concerns that the insurer is using it to reject claims en masse.

Insurance 131

Insurance 131

STAT

SEPTEMBER 22, 2023

LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced underwhelming results in a lung cancer trial over the summer. The drug, called datopotamab deruxtecan or Dato-DXd for short, succeeded on one of its primary endpoints of improving progression-free survival compared to chemotherapy in certain breast cancer patients who had previously been treated with oth

Chemotherapy 129

Chemotherapy 129

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

SEPTEMBER 22, 2023

Catholic healthcare giant CommonSpirit Health has reported a $1.4 billion operating loss (-4.1% operating margin) and a net loss of $259 million for its 2023 fiscal year, which ended June 30, accor | The 145-hospital nonprofit system's improving volumes were undercut by lagging reimbursement, high costs and a cybersecurity incident. But, fourth-quarter labor costs were somewhat checked by the health system eliminating "approximately 2,000" full-time jobs.

Hospitals 124

Hospitals 124

pharmaphorum

SEPTEMBER 22, 2023

Machine learning puts virtual drug screening into high gear Phil.

124

124

Drug Store News

SEPTEMBER 22, 2023

Walgreen’s partnership with Village Medical—and its investment in micro-fulfillment technology—is crucial to Walgreen’s future in fulfilling its mission of caring for patients.

122

122

STAT

SEPTEMBER 22, 2023

In March 2022, one of us, Kristina, was in Ukraine, running a training on a chilly day. Several hours into the training, one of the soldiers’ faces began to crumple, close to tears. The unit had just received a combat stress management skills training, including a box breathing exercise , in the field outside of a converted military base in Chernihiv near Ukraine’s borders with Belarus and Russia.

115

115

Fierce Pharma

SEPTEMBER 22, 2023

Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. | Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. Following a series of trial shortfalls this year in melanoma, colorectal cancer and head and neck squamous cell carcinoma, the duo has missed the mark in yet another set of clinical trials—this time in non-small cell lung cancer.

114

114

pharmaphorum

SEPTEMBER 22, 2023

Seagen hails ‘practice-changing’ trial in bladder cancer Phil.

111

111

STAT

SEPTEMBER 22, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda includes promenading with the official mascots and a listening party where the rotation will include this , this , this and this , and we will wrap up by observing some ancient rituals.

Department of Veterans Affairs 108

Department of Veterans Affairs Compounding Pharmacies Compounding Chemotherapy 108

Drug Store News

SEPTEMBER 22, 2023

Three in four Gen Z and Millennials are placing small orders for a single meal or recipe, reflecting a comfort with delivery services.

106

106

The Checkup by Singlecare

SEPTEMBER 22, 2023

“Tripledemic.” That’s the term floating around this season as healthcare providers gear up for the triple threat of flu , COVID-19 , and RSV (respiratory syncytial virus). It’s that time of year when coworkers call in sick, throats get scratchy, and kids seem to develop chronic coughs and sniffles. We know that basic measures like drinking fluids and taking over-the-counter medications can help ease uncomfortable symptoms.

Vaccines 105

Vaccines Immunization Insurance FDA 105

pharmaphorum

SEPTEMBER 22, 2023

Travere weaker after Filspari fails confirmatory trial Phil.

105

105

European Pharmaceutical Review

SEPTEMBER 22, 2023

The National Institute for Health and Care Excellence (NICE) have for the first time, recommended a IL-23p19 targeted biologic for adults with moderate to severe active ulcerative colitis in Great Britain. Eli Lilly’s mirikizumab (OMVOH ® ▼) is indicated for these patients when conventional or biological treatment cannot be tolerated, or the condition has not responded well enough or lost response to treatment.

105

105

pharmaphorum

SEPTEMBER 22, 2023

AZ, Daiichi Sankyo cue up TROP2 drug filing in breast cancer Phil.

105

105

Pharmaceutical Commerce

SEPTEMBER 22, 2023

An analysis by 3 Axis Advisors has found that there is a large variability in pharmacy reimbursement of prescription drugs depending on PBM contracts with insurers. This creates a system with huge inconsistencies on the prices of both generics and branded products.

Insurance 105

Insurance 105

Drug Store News

SEPTEMBER 22, 2023

The Barrier Renew line, developed with dermatologists, uses ceramides, antioxidants and prebiotics.

105

105

STAT

SEPTEMBER 22, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

101

101